Products Categories
CAS No.: | 555-65-7 |
---|---|
Name: | Brocresine |
Molecular Structure: | |
Formula: | C7H8 Br N O2 |
Molecular Weight: | 218.05 |
Synonyms: | m-Cresol, a-(aminooxy)-6-bromo- (7CI,8CI);3-Hydroxy-4-bromobenzyloxyamine; 4-Bromo-3-hydroxybenzyloxyamine; Brocresin; Brocresine;CL 54998; NSD 1055; m-Hydroxy-p-bromobenzyloxyamine; a-(Aminooxy)-6-bromo-m-cresol |
Density: | 1.672g/cm3 |
Boiling Point: | 347.3°Cat760mmHg |
Flash Point: | 163.9°C |
Safety: | Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and Br−. |
PSA: | 55.48000 |
LogP: | 2.24530 |
Chemistry informtion about Brocresine (CAS NO.555-65-7) is:
IUPAC Name: 5-(Aminooxymethyl)-2-Bromopheno
Synonyms: Brocresine ; 5-(Aminooxy)methyl-2-bromophenol ; Brocresin ; CL-54998 ; NSD-1055
MF: C7H8BrNO2
MW: 218.047920 g/mol
Density: 1.672 g/cm3
Flash Point: 163.9 °C
Boiling Point: 347.3 °C at 760 mmHg
Vapour Pressure: 2.7E-05 mmHg at 25°C
Enthalpy of Vaporization: 61.5 kJ/mol
Following is the molecular structure of Brocresine (CAS NO.555-65-7) is:
Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and Br−.
Brocresine (CAS NO.555-65-7), an aromatic L-amino acid decarboxylase inhibitor with both a peripheral and central action was shown to potentiate the therapeutic effect of levodopa in Parkinson's disease. The search for useful decarboxylase inhibitors therefore need not be limited to agents that do not pass the blood/brain barrier.